
SpringWorks Therapeutics Surges Amid Pharma Uncertainty — Is This the Year for a Spike?
SpringWorks Therapeutics, Inc. is a leading performer in the pharma sector, boasting a 65.65% year-to-date increase in 2025. The company’s flagship drug, OGSIVEO, approved